Lorito, N., Bacci, M., Smiriglia, A., Mannelli, M., Parri, M., Comito, G., . . . Morandi, A. (2020). Glucose Metabolic Reprogramming of ER(+) Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib. Cells.
Chicago Style CitationLorito, Nicla, et al. "Glucose Metabolic Reprogramming of ER(+) Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib." Cells 2020.
Cita MLALorito, Nicla, et al. "Glucose Metabolic Reprogramming of ER(+) Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib." Cells 2020.
Atenció: Aquestes cites poden no estar 100% correctes.